Statistics for Off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: a systematic review and meta-analysis
Total visits
| views | |
|---|---|
| Off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: a systematic review and meta-analysis | 32 |
Total visits per month
| views | |
|---|---|
| December 2024 | 8 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_a systematic review and meta-analysis.pdf | 6 |
| Off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_a systematic review and meta-analysis.pdf(legacy) | 5 |
Top country views
| views | |
|---|---|
| United States | 10 |
| India | 8 |
| Australia | 7 |
| China | 4 |
| Portugal | 2 |
| Ukraine | 2 |
| Mongolia | 1 |
Top city views
| views | |
|---|---|
| Delhi | 3 |